Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer.
No Thumbnail Available
Embargo End Date
ICR Authors
Authors
Pezaro, CJ
Omlin, A
Mastris, K
ANZUP Consumer Advisory Panel,
Attard, G
Beer, TM
Chi, KN
Chowdhury, S
Davis, ID
Drake, CG
de Bono, JS
Efstathiou, E
Gravis, G
Higano, CS
Hussain, M
James, N
Logothetis, CJ
Morgans, A
Parker, C
Ryan, CJ
Saad, F
Sartor, O
Small, EJ
Sternberg, CN
Sweeney, CJ
Tannock, I
Tombal, B
Gillessen, S
Omlin, A
Mastris, K
ANZUP Consumer Advisory Panel,
Attard, G
Beer, TM
Chi, KN
Chowdhury, S
Davis, ID
Drake, CG
de Bono, JS
Efstathiou, E
Gravis, G
Higano, CS
Hussain, M
James, N
Logothetis, CJ
Morgans, A
Parker, C
Ryan, CJ
Saad, F
Sartor, O
Small, EJ
Sternberg, CN
Sweeney, CJ
Tannock, I
Tombal, B
Gillessen, S
Document Type
Journal Article
Date
2017-08-01
Date Accepted
2017-06-19
Abstract
Citation
Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 28 (8), pp. 1692 - 1694
Rights
Source Title
Publisher
OXFORD UNIV PRESS
ISSN
0923-7534
eISSN
1569-8041
Research Team
Prostate Cancer Targeted Therapy Group
Treatment Resistance
Prostate and Bladder Cancer Research
Treatment Resistance
Prostate and Bladder Cancer Research